Additional file 1 of The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes

Supplementary material 1: Supplementary figure 1. Kaplan-Meier survival curves for (A) disease-free and (B) overall survival according to the types of PAT in the TPMN group. TPMN, tumors without micropapillary subtype; PAT, postoperative adjuvant treatment; non-PAT, observation; TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; ACT, adjuvant chemotherapy